Thomas McCauley
Chief Tech/Sci/R&D Officer at OMEGA THERAPEUTICS, INC.
Net worth: 49 764 $ as of 2024-04-29
Profile
Thomas McCauley is currently the Chief Scientific Officer at Omega Therapeutics, Inc. He previously held the position of Chief Scientific Officer at Translate Bio, Inc. from 2016 to 2018 and at Zikani Therapeutics, Inc. from 2018 to 2019.
Prior to that, he was the Vice President at Shire Pharmaceuticals, Inc. from 2010 to 2016.
Dr. McCauley completed his undergraduate degree at Cornell University and obtained his doctorate from The University of Alabama at Birmingham.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OMEGA THERAPEUTICS, INC.
0.04% | 2024-02-06 | 21,176 ( 0.04% ) | 49 764 $ | 2024-04-29 |
Thomas McCauley active positions
| Companies | Position | Start |
|---|---|---|
| OMEGA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-06-30 |
Former positions of Thomas McCauley
| Companies | Position | End |
|---|---|---|
Zikani Therapeutics, Inc.
 Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA. | Corporate Officer/Principal | 2019-06-30 |
| TRANSLATE BIO, INC. | Corporate Officer/Principal | 2018-03-31 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | 2016-07-31 |
Training of Thomas McCauley
| The University of Alabama at Birmingham | Doctorate Degree |
| Cornell University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| OMEGA THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Zikani Therapeutics, Inc.
Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA. | Retail Trade |
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
- Stock Market
- Insiders
- Thomas McCauley
